1464.1000 -33.70 (-2.25%)
NSE Nov 14, 2025 15:31 PM
Volume: 118.3K
High vol. this week

1464.10
-2.25%
ICICI Securities Limited
Jupiter Life Line Hospital’s (Jupiter) Q3FY25 result undershot our expectation. Revenue growth of 17.6% was driven by its Pune/Indore hospitals while price hike fuelled modest growth at the Thane hospital. Dombivli (200–220 beds) hospital is likely to commence operations in Q1FY27.
Prabhudas Lilladhar increased Buy price target of Jupiter Life Line Hospitals Ltd. to 1800.0 on 11 Nov, 2025.
More from Jupiter Life Line Hospitals Ltd.
Recommended